A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.
This pilot study tested the effectiveness of transcutaneous electric acupoint stimulation (TEAS) as an adjunctive treatment for inpatients receiving opioid detoxification with buprenorphine-naloxone at a private psychiatric hospital. Participants (N = 48) were randomly assigned to active or sham TEAS and received three 30-minute treatments daily for 3 to 4 days. In active TEAS, current was set to maximal tolerable intensity (8-15 mA); in sham TEAS, it was set to 1 mA. By 2 weeks postdischarge, participants in active TEAS were less likely to have used any drugs (35% vs. 77%, p < .05). They also reported greater improvements in pain interference (F = 4.52, p < .05) and physical health (F = 4.84, p < .01) over time. TEAS is an acceptable, inexpensive adjunctive treatment that is feasible to implement on an inpatient unit and may be a beneficial adjunct to pharmacological treatments for opioid detoxification.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Transcutaneous Electric Nerve Stimulation
- Time Factors
- Survival Analysis
- Substance Withdrawal Syndrome
- Substance Abuse
- Patient Selection
- Pain
- Opioid-Related Disorders
- Narcotic Antagonists
- Naloxone
Citation
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- Transcutaneous Electric Nerve Stimulation
- Time Factors
- Survival Analysis
- Substance Withdrawal Syndrome
- Substance Abuse
- Patient Selection
- Pain
- Opioid-Related Disorders
- Narcotic Antagonists
- Naloxone